Skip to main content
logo
Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
67.23
+7.35 (12.27%)
At close: Mar 31, 2026, 4:00 PM EDT
67.25
+0.02 (0.03%)
After-hours: Mar 31, 2026, 7:53 PM EDT

Inhibrx Biosciences Revenue

In the year 2025, Inhibrx Biosciences had annual revenue of $1.30M with 550.00% growth.

Revenue (ttm)
$1.30M
Revenue Growth
+550.00%
P/S Ratio
755.41
Revenue / Employee
$11,818
Employees
110
Market Cap
982.03M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.30M1.10M550.00%
Dec 31, 2024200.00K-1.60M-88.89%
Dec 31, 20231.80M-392.00K-17.88%
Dec 31, 20222.19M-5.04M-69.69%
Dec 31, 20217.23M-5.66M-43.89%
Dec 31, 202012.89M-323.00K-2.44%
Dec 31, 201913.21M4.62M53.71%
Dec 31, 20188.60M204.00K2.43%
Dec 31, 20178.39M1.72M25.86%
Dec 31, 20166.67M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Xeris Biopharma Holdings291.85M
Geron183.88M
CytomX Therapeutics76.20M
AbCellera Biologics75.13M
KalVista Pharmaceuticals73.62M
EyePoint31.37M
Inventiva19.93M
uniQure16.10M
Revenue Rankings

INBX News

More News